Viewing nowCombinationAmdikabq 30/2.5 mg Tablets
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 202300141 · Approved 2023.01.06 · Insurance code 661905770
Treatment of essential hypertension inadequately controlled with fimasartan monotherapy
This medication helps to lower blood pressure more effectively in patients with essential hypertension who are not sufficiently controlled on monotherapy with pimodivir potassium. It is used to improve blood pressure control and reduce the risk of cardiovascular disease.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication, certain kidney diseases, liver dysfunction, biliary obstruction, and certain genetic metabolic disorders should not take this medication. Patients with depleted blood volume or sodium, impaired kidney function, renal artery hypertension, etc. should be cautious, as hypotension or worsening of kidney function may occur when taking this medication. Side effects such as dizziness, headache, edema, urinary disorders, insomnia, and flushing may occur, and in rare cases, severe kidney problems or allergic reactions may also occur. Due to the potential risk of hypotension, blood pressure and electrolyte status should be regularly monitored, particularly in patients on high-dose diuretics who need to be aware of symptoms of low blood pressure. This medication may interact with other antihypertensives, potassium-sparing diuretics, lithium preparations, and non-steroidal anti-inflammatory drugs, so it is critical to inform your healthcare provider of any other medications being taken. Pregnant or breastfeeding women are advised to avoid this medication, and careful consideration should be given in consultation with a healthcare professional if needed. Safety and efficacy in patients under 18 years of age have not been established, so its use is not recommended. Elderly patients may be more sensitive to this medication, so caution is advised when taking it. Patients with moderate to severe liver dysfunction should not take this medication. In case of overdose, severe hypotension and cardiac issues may occur; immediate medical attention should be sought, and emergency treatment may be necessary. This medication should be stored out of reach of children, and transferring it to another container can lead to quality degradation or accidents, which should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to pass through. Additionally, it is important to maintain a temperature between 1 and 30 degrees Celsius when storing the medication to preserve its effectiveness.
White, rounded square film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.